SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank36
3Y CAGR-11.1%
5Y CAGR-4.1%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-11.1%/yr
Annual compound
5Y CAGR
-4.1%/yr
Recent deceleration
Percentile
P36
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202513.88%
202411.50%
202319.75%
202219.77%
20212.96%
202017.11%
201914.21%
2018-30.09%
20178.58%
20166.10%